查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1318912

药物研发服务市场：按流程、药物类型、服务类型、治疗领域、最终用户 - 2023-2030 年全球预测

Drug Discovery Services Market by Process, Drug Type, Service type, Therapeutic Area, End-user - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

全球药物研发服务市场预计到2023年将达到217.7亿美元，复合年增长率为14.27%，大幅成长，预计到2030年将达到557.5亿美元。

FPNV定位矩阵

FPNV 定位矩阵对于评估全球药物研发服务市场至关重要。透过检查业务策略和产品满意度的关键指标，我们对供应商进行全面评估，使您能够根据您的特定需求做出明智的资讯。这种进阶分析将供应商分为四个像限，并取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市占率分析

市场占有率分析可以深入了解供应商在特定市场领域的当前地位。比较供应商对总收入、基本客群和其他关键指标的贡献，可以帮助公司更好地了解他们在争夺市场份额时的表现以及面临的情况。该分析还揭示了特定行业的竞争程度、累积和合併的优势以及研究基准年的合併特征。

本报告提供了以下几点见解：

1. 市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2. 市场开发：提供有关利润丰厚的新兴市场的详细资讯，并分析其在成熟市场的渗透率。

3. 市场多元化：提供有关新产品发布、未开发领域、最新发展和投资的详细资讯。

4.市场趋势：全面了解COVID-19、俄罗斯-乌克兰衝突和高通膨的累积影响。

5.竞争评估与资讯：对主要企业的市场占有率、策略、产品、认证、法规状况、专利状况、製造能力等进行综合评估。

6. 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告回答了以下问题：

1.药物研发服务的全球市场规模与预测为何？

2.在预测期内，COVID-19 对全球药物研发服务市场的阻碍因素和影响为何？

3. 在预测期内，全球药物研发服务市场需要投资哪些产品/细分市场/应用/领域？

4.你们在全球药物研发服务市场的竞争策略是什么？

5. 全球药物研发服务市场的技术趋势和法律规范是什么？

6.全球药物研发服务市场主要供应商的市占率为何？

7. 哪些型态和策略性措施被认为适合进入全球药物研发服务市场？

目录

第1章前言

第2章调查方法

第3章执行摘要

第4章市场概况

第5章市场洞察

  • 市场动态
    • 促进因素
      • 加大医药及生物製药产业研发投入
      • 分析测试和临床试验服务外包需求显着增加
      • 罕见疾病及罕见疾病药物研究
    • 抑制因素
      • 昂贵的药物研发发现和开发
    • 机会
      • 专注于生物製剂开发和药物研发
      • 专利到期的可能性
    • 任务
      • 关于药物研发和动物使用的严格政府法规
  • 市场趋势
  • COVID-19 的累积影响
  • 俄罗斯-乌克兰衝突的累积影响
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法律规范
  • 客户客製化

第6章服务市场：依流程

  • 候选人检验
  • 点选读取识别
  • 潜在客户最佳化
  • 目标选择
  • 目标检验

第7章服务市场

  • 生物製品
  • 低分子

第8章服务市场：依服务类型

  • 生物服务
  • 化学服务

第9章服务市场

  • 心血管疾病
  • 消化器官系统疾病
  • 神经病学
  • 肿瘤学

第10章服务市场：依最终用户分类

  • 学术机构
  • 製药和生物技术公司

第11章美洲药物研发服务市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第12章亚太药物研发服务市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第13章欧洲、中东和非洲药物研发服务市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第14章竞争形势

  • FPNV定位矩阵
  • 市占率分析：主要企业
  • 竞争情境分析：主要企业

第15章上市公司名单

第16章附录

  • 讨论指南
  • 关于许可证和定价
Product Code: MRR-6611A5111690

The Global Drug Discovery Services Market is forecasted to grow significantly, with a projected USD 21.77 billion in 2023 at a CAGR of 14.27% and expected to reach a staggering USD 55.75 billion by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Drug Discovery Services Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Drug Discovery Services Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Process, market is studied across Candidate Validation, Hit-to-Lead Identification, Lead Optimization, Target Selection, and Target Validation. The Target Validation is projected to witness significant market share during forecast period.

Based on Drug Type, market is studied across Biologics and Small Molecules. The Biologics is projected to witness significant market share during forecast period.

Based on Service type, market is studied across Biology Services and Chemistry Services. The Chemistry Services is projected to witness significant market share during forecast period.

Based on Therapeutic Area, market is studied across Cardiovascular Diseases, Digestive System Diseases, Neurology, and Oncology. The Neurology is projected to witness significant market share during forecast period.

Based on End-user, market is studied across Academic Institutes and Pharmaceutical & Biotechnology Companies. The Academic Institutes is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Europe, Middle East & Africa is projected to witness significant market share during forecast period.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Drug Discovery Services Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Drug Discovery Services Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Drug Discovery Services Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Drug Discovery Services Market?

4. What is the competitive strategic window for opportunities in the Global Drug Discovery Services Market?

5. What are the technology trends and regulatory frameworks in the Global Drug Discovery Services Market?

6. What is the market share of the leading vendors in the Global Drug Discovery Services Market?

7. What modes and strategic moves are considered suitable for entering the Global Drug Discovery Services Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Drug Discovery Services Market, by Process, 2022 vs 2030
  • 4.3. Drug Discovery Services Market, by Drug Type, 2022 vs 2030
  • 4.4. Drug Discovery Services Market, by Service type, 2022 vs 2030
  • 4.5. Drug Discovery Services Market, by Therapeutic Area, 2022 vs 2030
  • 4.6. Drug Discovery Services Market, by End-user, 2022 vs 2030
  • 4.7. Drug Discovery Services Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing R&D investments in the pharmaceutical & biopharmaceutical industry
      • 5.1.1.2. Attractive rise in demand for outsourcing analytical testing and clinical trial services
      • 5.1.1.3. Research on rare diseases and orphan drugs
    • 5.1.2. Restraints
      • 5.1.2.1. Expensive drug discovery and development
    • 5.1.3. Opportunities
      • 5.1.3.1. Development in the biologics and focus on drug discovery
      • 5.1.3.2. Potential associated with expiry of patents
    • 5.1.4. Challenges
      • 5.1.4.1. Strict government rules for drug discovery and animal usage
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Drug Discovery Services Market, by Process

  • 6.1. Introduction
  • 6.2. Candidate Validation
  • 6.3. Hit-to-Lead Identification
  • 6.4. Lead Optimization
  • 6.5. Target Selection
  • 6.6. Target Validation

7. Drug Discovery Services Market, by Drug Type

  • 7.1. Introduction
  • 7.2. Biologics
  • 7.3. Small Molecules

8. Drug Discovery Services Market, by Service type

  • 8.1. Introduction
  • 8.2. Biology Services
  • 8.3. Chemistry Services

9. Drug Discovery Services Market, by Therapeutic Area

  • 9.1. Introduction
  • 9.2. Cardiovascular Diseases
  • 9.3. Digestive System Diseases
  • 9.4. Neurology
  • 9.5. Oncology

10. Drug Discovery Services Market, by End-user

  • 10.1. Introduction
  • 10.2. Academic Institutes
  • 10.3. Pharmaceutical & Biotechnology Companies

11. Americas Drug Discovery Services Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Drug Discovery Services Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Drug Discovery Services Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. FPNV Positioning Matrix
  • 14.2. Market Share Analysis, By Key Player
  • 14.3. Competitive Scenario Analysis, By Key Player

15. List of Company Mentioned

16. Appendix

  • 16.1. Discussion Guide
  • 16.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. DRUG DISCOVERY SERVICES MARKET RESEARCH PROCESS
  • FIGURE 2. DRUG DISCOVERY SERVICES MARKET SIZE, 2022 VS 2030
  • FIGURE 3. DRUG DISCOVERY SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2022 VS 2030 (%)
  • FIGURE 5. DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2022 VS 2030 (%)
  • FIGURE 6. DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2022 VS 2030 (%)
  • FIGURE 7. DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2022 VS 2030 (%)
  • FIGURE 8. DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
  • FIGURE 9. DRUG DISCOVERY SERVICES MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 10. DRUG DISCOVERY SERVICES MARKET DYNAMICS
  • FIGURE 11. DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES DRUG DISCOVERY SERVICES MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC DRUG DISCOVERY SERVICES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 20. DRUG DISCOVERY SERVICES MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 21. DRUG DISCOVERY SERVICES MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. DRUG DISCOVERY SERVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. DRUG DISCOVERY SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 5. DRUG DISCOVERY SERVICES MARKET SIZE, BY CANDIDATE VALIDATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. DRUG DISCOVERY SERVICES MARKET SIZE, BY HIT-TO-LEAD IDENTIFICATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. DRUG DISCOVERY SERVICES MARKET SIZE, BY LEAD OPTIMIZATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. DRUG DISCOVERY SERVICES MARKET SIZE, BY TARGET SELECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. DRUG DISCOVERY SERVICES MARKET SIZE, BY TARGET VALIDATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 11. DRUG DISCOVERY SERVICES MARKET SIZE, BY BIOLOGICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. DRUG DISCOVERY SERVICES MARKET SIZE, BY SMALL MOLECULES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 14. DRUG DISCOVERY SERVICES MARKET SIZE, BY BIOLOGY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. DRUG DISCOVERY SERVICES MARKET SIZE, BY CHEMISTRY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 17. DRUG DISCOVERY SERVICES MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. DRUG DISCOVERY SERVICES MARKET SIZE, BY DIGESTIVE SYSTEM DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. DRUG DISCOVERY SERVICES MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. DRUG DISCOVERY SERVICES MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 22. DRUG DISCOVERY SERVICES MARKET SIZE, BY ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. DRUG DISCOVERY SERVICES MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES DRUG DISCOVERY SERVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC DRUG DISCOVERY SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. AUSTRALIA DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 63. AUSTRALIA DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. AUSTRALIA DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. CHINA DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 68. CHINA DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. CHINA DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. INDIA DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 73. INDIA DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. INDIA DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. INDONESIA DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 78. INDONESIA DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. INDONESIA DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. JAPAN DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 83. JAPAN DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. JAPAN DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. MALAYSIA DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 88. MALAYSIA DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. MALAYSIA DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. MALAYSIA DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. PHILIPPINES DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 93. PHILIPPINES DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. PHILIPPINES DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. PHILIPPINES DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. SINGAPORE DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 98. SINGAPORE DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. SINGAPORE DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. SINGAPORE DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. SOUTH KOREA DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 103. SOUTH KOREA DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. SOUTH KOREA DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. SOUTH KOREA DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. TAIWAN DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 108. TAIWAN DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. TAIWAN DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. TAIWAN DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 112. THAILAND DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 113. THAILAND DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. THAILAND DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. THAILAND DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 117. VIETNAM DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 118. VIETNAM DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. VIETNAM DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. VIETNAM DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. DENMARK DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 129. DENMARK DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. DENMARK DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. DENMARK DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 133. EGYPT DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 134. EGYPT DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. EGYPT DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. EGYPT DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. FINLAND DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 139. FINLAND DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. FINLAND DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. FINLAND DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. FRANCE DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 144. FRANCE DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. FRANCE DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. FRANCE DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 148. GERMANY DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 149. GERMANY DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. GERMANY DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. GERMANY DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 153. ISRAEL DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 154. ISRAEL DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. ISRAEL DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. ISRAEL DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 158. ITALY DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 159. ITALY DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. ITALY DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. ITALY DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 163. NETHERLANDS DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 164. NETHERLANDS DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. NETHERLANDS DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. NETHERLANDS DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 168. NIGERIA DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 169. NIGERIA DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. NIGERIA DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. NIGERIA DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 173. NORWAY DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 174. NORWAY DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. NORWAY DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. NORWAY DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 178. POLAND DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 179. POLAND DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. POLAND DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. POLAND DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 183. QATAR DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 184. QATAR DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. QATAR DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. QATAR DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 188. RUSSIA DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 189. RUSSIA DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. RUSSIA DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 191. RUSSIA DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 193. SAUDI ARABIA DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 194. SAUDI ARABIA DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 195. SAUDI ARABIA DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 196. SAUDI ARABIA DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 198. SOUTH AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 199. SOUTH AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 200. SOUTH AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 203. SPAIN DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 204. SPAIN DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 205. SPAIN DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 206. SPAIN DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 208. SWEDEN DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 209. SWEDEN DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 210. SWEDEN DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 211. SWEDEN DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 213. SWITZERLAND DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 214. SWITZERLAND DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 215. SWITZERLAND DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 216. SWITZERLAND DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 218. TURKEY DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 219. TURKEY DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 220. TURKEY DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 221. TURKEY DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 223. UNITED ARAB EMIRATES DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 224. UNITED ARAB EMIRATES DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 225. UNITED ARAB EMIRATES DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED ARAB EMIRATES DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED KINGDOM DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED KINGDOM DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED KINGDOM DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 233. DRUG DISCOVERY SERVICES MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 234. DRUG DISCOVERY SERVICES MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 235. DRUG DISCOVERY SERVICES MARKET LICENSE & PRICING